ABVC BioPharma, Inc. Operating Lease, Liability, Current
ABVC BioPharma, Inc. (ABVC) had Operating Lease, Liability, Current of $358.11 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability, Current $358.11K.
- 2026-03-31: Operating Lease, Liability, Current $332.25K.
- 2025-12-31: Operating Lease, Liability, Current $317.56K.
- 2025-09-30: Operating Lease, Liability, Current $199.34K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $358.11K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $332.25K 10-Q · filed 2026-05-18 |
| 2025-12-31 | $317.56K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $199.34K 10-Q/A · filed 2026-03-03 |
| 2025-06-30 | $282.19K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $366.48K 10-Q · filed 2025-04-30 |
| 2024-12-31 | $403.58K 10-Q/A · filed 2026-03-03 |
| 2024-09-30 | $365.46K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $378.20K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $389.87K 10-Q · filed 2024-05-17 |
| 2023-12-31 | $401.83K 10-K · filed 2025-04-15 |
| 2023-09-30 | $392.67K 10-Q · filed 2023-11-15 |
| 2023-06-30 | $390.50K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $387.33K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $369.31K 10-K · filed 2024-03-13 |
| 2022-09-30 | $363.75K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $350.28K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $349.01K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $347.10K 10-K · filed 2023-03-31 |
| 2021-09-30 | $342.13K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $337.17K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $331.18K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $316.18K 10-K · filed 2022-03-31 |
| 2020-09-30 | $311.74K 10-Q · filed 2020-11-17 |
| 2020-06-30 | $219.57K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $282.71K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $304.25K 10-K · filed 2021-03-16 |
| 2019-09-30 | $268.62K 10-Q · filed 2019-11-18 |
| 2019-06-30 | $279.21K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $286.21K 10-Q · filed 2019-05-28 |